Physician profile
Tiffany Bryan
NPI 1740787332
$1,756.03
in general payments reported to CMS, 2019-2025
25 companies · $798 in 2025
The $798 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.12 · 2022: $118 · 2023: $311 · 2024: $516 · 2025: $798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,612 · Entertainment: $13.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,612.07 |
| Entertainment | $13.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $375.21 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $171.22 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $146.46 | 2023-2025 | Vraylar |
| Novo Nordisk INC | $144.33 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $121.67 | 2022-2025 | |
| Amgen INC. | $93.78 | 2023-2025 | Repatha, Otezla, Otezla |
| Abiomed | $90.30 | 2025 | |
| Abbott Laboratories | $79.59 | 2024-2025 | Freestyle Libre 3 |
| Vital Connect, INC | $72.59 | 2025 | Vitalpatch Rtm |
| Glaxosmithkline, LLC. | $57.91 | 2020-2025 | Trelegy Ellipta |
| Inari Medical, INC. | $57.06 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Exact Sciences Corporation | $55.12 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.65 | 2023-2025 | Xifaxan, Trulance |
| Novartis Pharmaceuticals Corporation | $36.75 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.13 | 2023-2024 | Jardiance |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25.11 | 2024 | Wavewriter Alpha Prime 16 |
| Stryker Corporation | $21.73 | 2025 | Clottriever Bold Catheter |
| Medtronic, INC. | $19.66 | 2025 | Intellis Adaptivestim |
| Mylan Specialty L.P. | $18.54 | 2022 | |
| Dynavax Technologies Corporation | $17.04 | 2023 | Heplisav-B |
| Xeris Pharmaceuticals, INC. | $16.06 | 2023 | Gvoke Hypopen |
| Daiichi Sankyo INC. | $15.36 | 2025 | Injectafer |
| Biohaven Pharmaceutical Holding Company LTD. | $14.66 | 2022 | |
| Corcept Therapeutics | $14.54 | 2025 | Korlym |
| Optos, INC. | $13.56 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Bryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.